Committee advances bill on 340B drug distribution after debate over wholesalers, patient definition and state authority

The Senate Financial Institutions and Insurance Committee on March 18 advanced Senate Bill 284, a measure addressing 340B drug distribution, after adopting an amendment that removed wholesalers from certain prohibitions and after rejecting a state‑level definition of who qualifies as a "340B patient." The bill drew extended discussion about federal preemption, rural hospitals, pharmacies and how state action could interact with federal law.

Committee staff member Eileen described the amendment commonly called the "Murphy Amendment," which removes wholesalers and "virtual wholesalers" from the list of entities that "shall not directly or indirectly deny, restrict, prohibit, discriminate against, or otherwise limit the acquisition or delivery of a 340B drug to a covered entity or location otherwise authorized by a covered entity." The amendment also added language allowing the Board of Pharmacy to investigate complaints and to impose discipline, suspension or revocation of registrations or permits for persons or entities subject to board registration or permitting requirements. Senator Francisco moved that amendment; the committee approved it by voice vote.

A second amendment proposed a state definition of "340B patient" as "an individual who is low income, underinsured, and who does not qualify for Medicare or Medicaid." Senator Francisco moved that amendment and Senator Fagg seconded. Senator Warren raised a question about whether the federal 340B program defines a "340B patient." Eileen responded: "looking at the federal website the 340B program patients just need to be patients of a covered entity. So this definition would not necessarily conflict with that, but ... this definition is strictly for the purposes of this bill." After debate about whether the proposed definition would create a state means‑tested variation of a federal program and concerns about potential legal exposure or preemption, the committee rejected the patient‑definition amendment on a voice vote.

Committee members debated broader policy concerns. Senator Warren and others said the 340B program is federally administered and cautioned that the state could face litigation or create conflicts if it changes program definitions or imposes new requirements; Senator Warren said, "this is a federal program ... I'm wondering does the federal code define 340B patient or is this something that's created by this amendment?" Senator Rose argued that the Affordable Care Act provides coverage options and encouraged hospitals to help uninsured patients enroll in marketplace coverage.

Senator Gossage moved to table the bill as a substitute motion, citing the need for more time to vet fiscal and policy impacts; that substitute motion required an up‑or‑down vote and was decided by hand count after an initial voice vote produced unclear results. The hand count recorded three in favor and five opposed; the substitute motion to table failed. Senator Argebrecht then moved to report SB 284 favorably out of committee as amended; Senator Francisco seconded and the motion passed by voice vote. Later in the meeting Senator Fagg moved to remove the contents of House Bill 2,245 and insert the contents of SB 284 as amended (a content substitution); that motion failed after a hand count.

Committee members repeatedly raised concerns about whether the state can or should impose new enforcement tools or a new fund, how 340B funds are currently used by hospitals, and whether state action would meaningfully help rural hospitals or risk litigation. The committee advanced the bill to the next stage but recorded several members’ reservations and a call for further stakeholder and federal coordination on the program.